NIVF newgenivf.com: Company Value to Revenue Ratio

Public company logo of NewGenIvf Group (NIVF)

The EV/Revenue multiple on the GURU.Markets dynamic chart demonstrates the resilience of NewGenIvf Group Limited (NIVF), where -25.92 forms the current metric value. NewGenIvf Group Limited is implementing robotic systems in laboratories to automate biomaterial preparation. High equipment costs and strict ministerial oversight create barriers to entry, while the influx of medical tourists from China and Thailand ensures rapid growth of the client base.

NIVF NewGenIvf Corp: Company Value to Revenue in the range 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for NewGenIvf Group Ltd (NIVF)

- price and consensus price forecast:
Fundamental company valuation:NIVF newgenivf.com
Brand item of NewGenIvf Group

Steady demand for reproductive medicine services in Southeast Asia allows NewGenIvf Group Limited to effectively scale revenue through clinic diversification. An analysis of the company's EV/Sales ratio determines the total enterprise value, including net debt, relative to sales volumes, helping investors identify whether assets are overvalued or undervalued compared to industry peers, as reflected in the price action of this chart.

Competitor analysis

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|EV/Sales Multiple BTMD (Biote)|Enterprise Value-to-Revenue Coefficient JYNT (The Joint Corp.)|DCGO - Enterprise Value-to-Revenue Ratio|PIII: Enterprise Value-to-Revenue Ratio|GANX: EV/Sales Multiple|Company Value to Revenue EUDA Health|BMGL (Basel Medical Group) - EV/Sales Multiple|CLGN - Enterprise Value-to-Sales Ratio|Enterprise Value-to-Revenue Ratio Cuprina Holdings (CUPR)|Total Company Value-to-Revenue Ratio Concord Medical Services|EV/Sales Multiple AMS (ashs.com)|MEDIROM Healthcare Group Inc. (MRM) - Enterprise Value-to-Revenue Multiple|ALBT: Company Value to Revenue|Business Value to Revenue DHAI (DIH Holding US Inc.)|XAGE (Carmell Therapeutics) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple